ArticleDrugs & aging2026

Long-Term Proton Pump Inhibitor Therapy Is Common Among Older Adults: An 8-Year Finnish Nationwide Register Study.

Leeni Minkkinen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.